218 related articles for article (PubMed ID: 24358266)
1. Oscillatory underpinnings of mismatch negativity and their relationship with cognitive function in patients with schizophrenia.
Kaser M; Soltesz F; Lawrence P; Miller S; Dodds C; Croft R; Dudas RB; Zaman R; Fernandez-Egea E; Müller U; Dean A; Bullmore ET; Nathan PJ
PLoS One; 2013; 8(12):e83255. PubMed ID: 24358266
[TBL] [Abstract][Full Text] [Related]
2. Decomposing the constituent oscillatory dynamics underlying mismatch negativity generation in schizophrenia: Distinct relationships to clinical and cognitive functioning.
Hochberger WC; Joshi YB; Zhang W; Thomas ML; ; Braff DL; Swerdlow NR; Light GA
Int J Psychophysiol; 2019 Nov; 145():23-29. PubMed ID: 30586570
[TBL] [Abstract][Full Text] [Related]
3. A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
Lee M; Sehatpour P; Dias EC; Silipo GS; Kantrowitz JT; Martinez AM; Javitt DC
Schizophr Res; 2018 Jan; 191():10-17. PubMed ID: 28779851
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
[TBL] [Abstract][Full Text] [Related]
5. Mismatch negativity is a stronger indicator of functional outcomes than neurocognition or theory of mind in patients with schizophrenia.
Lee SH; Sung K; Lee KS; Moon E; Kim CG
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():213-9. PubMed ID: 24161665
[TBL] [Abstract][Full Text] [Related]
6. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
Light GA; Braff DL
Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
[TBL] [Abstract][Full Text] [Related]
7. Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
Zhou Z; Zhu H; Chen L
PLoS One; 2013; 8(1):e52186. PubMed ID: 23308105
[TBL] [Abstract][Full Text] [Related]
8. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
[TBL] [Abstract][Full Text] [Related]
9. Mismatch negativity latency and cognitive function in schizophrenia.
Kärgel C; Sartory G; Kariofillis D; Wiltfang J; Müller BW
PLoS One; 2014; 9(4):e84536. PubMed ID: 24740391
[TBL] [Abstract][Full Text] [Related]
10. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
[TBL] [Abstract][Full Text] [Related]
11. Mismatch negativity, social cognition, and functioning in schizophrenia patients.
Wynn JK; Sugar C; Horan WP; Kern R; Green MF
Biol Psychiatry; 2010 May; 67(10):940-7. PubMed ID: 20074704
[TBL] [Abstract][Full Text] [Related]
12. Visual mismatch negativity among patients with schizophrenia.
Urban A; Kremlácek J; Masopust J; Libiger J
Schizophr Res; 2008 Jul; 102(1-3):320-8. PubMed ID: 18472402
[TBL] [Abstract][Full Text] [Related]
13. Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia.
Xiong YB; Bo QJ; Wang CM; Tian Q; Liu Y; Wang CY
Front Behav Neurosci; 2019; 13():37. PubMed ID: 30894804
[No Abstract] [Full Text] [Related]
14. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.
Rasser PE; Schall U; Todd J; Michie PT; Ward PB; Johnston P; Helmbold K; Case V; Søyland A; Tooney PA; Thompson PM
Schizophr Bull; 2011 Jan; 37(1):131-40. PubMed ID: 19561058
[TBL] [Abstract][Full Text] [Related]
15. Neural substrates of normal and impaired preattentive sensory discrimination in large cohorts of nonpsychiatric subjects and schizophrenia patients as indexed by MMN and P3a change detection responses.
Takahashi H; Rissling AJ; Pascual-Marqui R; Kirihara K; Pela M; Sprock J; Braff DL; Light GA
Neuroimage; 2013 Feb; 66():594-603. PubMed ID: 23085112
[TBL] [Abstract][Full Text] [Related]
16. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
Koshiyama D; Miyakoshi M; Thomas ML; Joshi YB; Molina JL; Tanaka-Koshiyama K; Sprock J; Braff DL; Swerdlow NR; Light GA
Schizophr Res; 2021 Feb; 228():280-287. PubMed ID: 33493776
[TBL] [Abstract][Full Text] [Related]
17. Associated deficits in mismatch negativity generation and tone matching in schizophrenia.
Javitt DC; Shelley A; Ritter W
Clin Neurophysiol; 2000 Oct; 111(10):1733-7. PubMed ID: 11018486
[TBL] [Abstract][Full Text] [Related]
18. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.
McCleery A; Mathalon DH; Wynn JK; Roach BJ; Hellemann GS; Marder SR; Green MF
Psychol Med; 2019 May; 49(7):1195-1206. PubMed ID: 30642411
[TBL] [Abstract][Full Text] [Related]
19. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.
Javitt DC; Doneshka P; Grochowski S; Ritter W
Arch Gen Psychiatry; 1995 Jul; 52(7):550-8. PubMed ID: 7598631
[TBL] [Abstract][Full Text] [Related]
20. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
